What is Roundtrip?
Founded in 2016 and headquartered in Philadelphia, Roundtrip operates a sophisticated digital transportation marketplace designed to bridge the gap between patients and medical appointments. The platform addresses a critical pain point in the healthcare continuum: non-emergency medical transportation (NEMT). By streamlining the coordination of rides, Roundtrip improves patient outcomes, reduces missed appointment rates, and optimizes the operational efficiency of healthcare systems. The company's market position is defined by its ability to integrate seamlessly with existing electronic health records and clinical workflows, making it an essential utility for modern healthcare delivery.
How much funding has Roundtrip raised?
Roundtrip has raised a total of $11M across 3 funding rounds:
Angel/Seed
$1.9M
Series A
$5.1M
Unspecified
$4M
Angel/Seed (2018): $1.9M with participation from Ben Franklin Technology Partners Companies and M-1 Ventures
Series A (2019): $5.1M led by Johns Hopkins University, Mottly Ventures, and Ben Franklin Technology Partners of Southeastern Pennsylvania
Unspecified (2020): $4M supported by Grays Ferry Capital, UH Ventures, Mottly Ventures, and ZOLL Medical Corp.
Key Investors in Roundtrip
Mottly Ventures
An early-stage venture capital fund that leverages a strong brand community to support innovative startups, focusing on fostering inclusion and financial resilience.
Johns Hopkins University
A world-renowned private research university that engages in strategic investments to support advancements in medical technology and healthcare delivery.
Ben Franklin Technology Partners
A long-standing investment organization dedicated to fostering economic growth and technological innovation within the Southeastern Pennsylvania region.
What's next for Roundtrip?
Looking ahead, Roundtrip is poised to leverage its recent capital to deepen its penetration within the enterprise healthcare market. The company's roadmap likely includes the expansion of its service network and the integration of advanced predictive analytics to further reduce transit-related barriers to care. As the healthcare industry continues to shift toward value-based care models, Roundtrip's infrastructure will be instrumental in ensuring that transportation is no longer a social determinant of health that hinders patient recovery. Future growth will likely focus on strategic partnerships with large-scale health systems and insurance providers to standardize the patient transit experience.
See full Roundtrip company page
